Clinical Trial 38265

Houston, TX 77081


Summary:

Study 38265 Flyer
Click image to enlarge

Are you at Risk for Fatty Liver Disease (NASH) Without Even Knowing It?

NASH stands for non-alcoholic steatohepatitis. NASH occurs when there is a build-up of too much fat in the liver, accompanied by inflammation and damage. It occurs most often in people who are older, overweight and have diabetes or high cholesterol. It is estimated that around 30% of the general population have excess fat in their liver and up to 30% of these people have NASH. Although similar to alcoholic liver disease, it is not caused by drinking too much alcohol.

NASH is a "silent" liver disease. In the early stages, you may have few or no symptoms at all. In later stages, you could experience symptoms such as:

- a general feeling of discomfort or lack of energy
- abdominal ache in the upper right part of your belly

If left unchecked, NASH can worsen, causing permanent liver damage and scarring. There are currently no medicines available to treat patients with NASH.

The main purpose of each study is to investigate whether the study drug used is safe and effective in treating patients with NASH.


Qualified Participants Must:

• Be 50 years of age or older
• Be diabetic or borderline diabetic
• Be overweight or obese
• Have elevated liver enzymes (ALT) or have symtoms of liver disease (such as fatigue or abdominal pain)
• Have no recent history or alcohol or drug abuse, or high consumption of alcohol


Qualified Participants May Receive:

  • Investigational medication, laboratory work, and evaluations at no charge
  • Compensation for time and travel costs


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.